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TENDONS:  
STRUCTURE, FUNCTION AND CHALLENGES TO CLINICAL TREATMENT 
CALVIN C. WANG 
ABSTRACT 
As dense connective tissues, tendons play a vital role in the transmission of contractile 
forces from muscle to bone. This link between muscles and bones provides the means in 
transferring tensile forces produced by muscles on to the connected bone. During 
movement, tendons slide over surrounding bony and articular surfaces and are thus 
commonly subjected to shear and compression forces in addition to tensile force. 
Fibrillar collagen, proteoglycan and various glycoproteins make up the composition of 
tendinous tissue and contribute to its ability to withstand these forces. Tendons contain a 
distinct population of cells, called tenocytes. Tenocytes undertake a flattened morphology 
within the tendon matrix and contain cytoplasmic projections which extend longitudinally 
and laterally towards other tenocytes. An intercellular network of cells thus maintains the 
extracellular environment of the tendon and allows a coordinated response to external 
mechanical stimuli. Defects to load-bearing connective tissue elements such as tendons 
whether due to trauma, overuse, age-related diseases or degenerative diseases, are often 
limited in their healing potential and thus contributes often to persistent, chronic clinical 
symptoms. Chronic disease, overuse or acute injuries damages the tendon. This damage 
compromises the transmission of tensile forces and because of the hypovascularity of 
some tendinous tissues and many other reasons, a healing response often is severely 
insufficient in regenerating tissue back to its original constitution. Even the best treatment 
options for such tendinopathies, supplemented with the body’s own healing response fail 
  vi 
to produce quality outcomes. An understanding of the molecular, cellular and mechanical 
characteristics of tenocytes, tendon matrix and the tendon system as a whole will be vital 
for the development of effective therapies for all tendinopathies. It is the goal of this 
current work to outline the current molecular, cellular, mechanical and clinical 
understanding of tendons. A broad address to tendon biology should help illustrate the 
key dimensional aspects that must be considered when attempting the effective 
translation of research into useful clinical therapies. 
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INTRODUCTION 
Tendons function vitally in the musculoskeletal system, lying at the interface of muscle 
and bone. They allow the transmission of muscle contraction force onto bone to produce 
skeletal movement. Tendons possess high resilience to withstanding high tensile forces, 
however, as with other elements of the musculoskeletal system, exposure to various 
strengths of mechanical forces make tendon highly susceptible to many clinical 
pathologies due to acute trauma and/or chronic overuse.  While clinical treatments exist 
for various tendon disorders, addressing tendon pathologies still remains a clinical 
challenge as treatment strategies remain mostly insufficient to meet the needs for full 
restoration to normal mechanical capability. An insufficient understanding of tendon 
biology and the biological processes underlying injury and healing, contributes to the 
present struggle in identifying fully effective treatment options for tendon injuries.  In 
this project, I describe the molecular and mechanical properties of tendon in the context 
of clinical treatments and tendon healing. I wish to illustrate our current understanding of 
tendon biology and how current research continues to steer the development of novel 
treatments for tendon injury and disease.  
 
The study of tendon proves difficult because of the similarity of tendon to most other 
connective tissues which are similarly rich in type 1 collagen. What makes tendon unique 
however, is the organized arrangement of type I collagen and diverse ECM enriched 
within the collagenous tissue. Thus a natural question which evolves from such an 
observation is how tendinous tissues achieve such spatial arrangement of collagen fibers 
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during development, affording an effective function in mechanical transduction between 
muscle and bone. Indeed, in disease and injury it is often the disorganized matrix which 
results from the healing process in tendon pathology that causes tendon to lose its optimal 
function and original mechanical properties. In order to better steer clinical development, 
investigators must effectively select preclinical models representative of the 
pathology/disorder/injury they wish to address.  
 
All aspects including molecular, mechanical and clinical evidence must be considered 
when devising productive investigations, and when developing new treatment strategies 
for future use. 
 
TENDON BASIC STRUCTURE AND ANATOMY 
Tendons interface at both the muscle and the bone. The force transmitting tendons 
located at the muscle insertion have a principle role in relaying the contractile force of the 
muscle into skeletal movement. Conversely, tendons located at the muscle origin 
typically have an anchoring, structural role (Benjamin et al., 2000).  
 
At the myotendinous junction, a connection between the perimysium and the 
intramuscular parts of the tendon plays an important role that allows myofibers to be 
continuous with the tendon. This continuity afforded by the collagen network of the 
perimysium allows the force of muscle contraction to be transmitted to tendon and 
ultimately to skeletal movement (Passerieux, et al., 2007).   
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Tenocytes: A fibroblast type cell 
Tenocytes are a specific population of cells in the tendon that highly resembles 
specialized fibroblast, and remain in close proximity to collagen fibrils. Tenocytes are 
responsible for the maintenance of the extracellular environment in tendon. During 
development, tenocytes secrete a variety of extracellular components that associate with 
fibrils and fiber bundles (Birk et al., 1994). Tenocytes take on a flattened appearance 
when observed under the microscope because of the space they occupy between collagen 
fibrils (Figure 1). Tenocytes have thin long cytoplasmic projections that establish a 
network of interconnections with other tenocytes, facilitating intercellular communication 
via gap junctions.  Immuno-labeling of the gap junction proteins, connexin 43 and 
connexin 32, produce a positive signal at areas where these thin processes meet. 
(McNelly et al, 1997).  Connexin 32 link tenocytes in the longitudinal row whereas 
connexin 43 links tenocytes both laterally and longitudinally (Wagget et al., 2006).  
Figure 1. Longitudinal Section of Tenocytes 
 
 
 
 
 
 
Tenocytes sit between the fibrillar collagen and exhibit a flattened morphology. (Taken from Clegg et al. 2007) 
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Because tenocytes strongly resemble fibroblasts, identifying markers unique to tendon is 
critical to effectively identify and study tendons. Tendon cells share similarities to 
ligaments in genetic profile and express a pattern of several distinct markers useful for 
distinguishing tenocytes from other similar cell populations. Notably, tenocytes are 
associated by the expression of scleraxis and tenomodulin. While scleraxis and 
tenomodulin are also expressed in other mesodermal tissues during development, the 
combination of scleraxis and tenomodulin provides a more confident means to identify 
cells of tendon lineage. One of the shortcomings of our understanding in tendon biology 
is the lack of distinguishing markers that fully delineate between tendon stem, progenitor, 
and mature cells from other mesenchymal cells.  
 
In comparison to the more compressed tenocytes in the majority of the tendon, tendon 
cells located distally in the tendon within the fibrocartilaginous regions of the tendon near 
the bone attachment exhibit a more spherical shape. The spherical shape of tenocytes near 
this end of the tendon may suggest an adaptation necessary for the different kind of 
stresses exhibited at bone attachment site. A spherical shape may suggest a looser 
attachment to the matrix, and thus a characteristic which may minimize the deformation 
of tenocytes during the compressive forces experienced. It is believed that in this region, 
the content of tenascin-c, an anti-adhesive protein, helps tenocytes associate more loosely 
with the matrix.  
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Immunoblot analyses indicate that elevated tenascin-C levels are observed at the 
fibrocartilaginous region of the tendon (Martin et al., 2003). In vitro culture studies 
similarly show that tenascin-C expression in tendon cells are elevated at the distal tendon. 
The inability of tendon cells to attach to fibronectin was also observed upon treatment of 
cultured tendon cells with purified tenascin-C. Together these results strongly support the 
anti-adhesive role of tenascin and suggest that such anti-adhesive properties are more 
focused and necessarily present at the distal ends of the tendon (Mehr et al., 2000). 
 
TPSCS: stem cell like cells in the tendon 
In addition to tenocytes, tendon harbor a stem cell population called TSPCs that display  
properties  similar to mesenchymal stem cells. Isolated TSPCs differentiate into tendon 
like tissue during in vitro expansion.  These TSPCs exhibit increased expression of 
biglycan and fibromodulin. Compared to other populations of stem cells like BMSCs 
(bone marrow stem cells), TPSCs express higher amounts of the transcription factors 
Scleraxis, sox9,and Runx2, suggesting a differentiation preference to tendon.  
 
TSPCs also express higher levels of tenomodulin (TNMD) compared to BMSCs. 
Expression of these tendon markers suggest that TSPCs may be considered tendon stem 
cells. Flow cytometric analysis of TSPCS, indicate that 96% of the cells expressed the 
stem cell antigen-1 and a large majority also express fibroblast markers distinct from that 
of BMSCs. This antigen expression pattern, along with observed expression profile of 
various proteins suggests a cell type with stem cell characteristics, but trending towards a 
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tendon cell precursor population. When expanded and transplanted on various carriers, 
GFP expressing TSPCs generated tendon like properties including the parallel alignments 
of collagen fibers (Bi et al., 2007). Such results strengthen the idea that these TSPCs are 
pool of cells, which could facilitate regeneration of tendon cells. The existence of these 
cells provides yet another element in tendon biology that should be seriously considered 
when developing new therapies. There is potential that the controlled and effective 
stimulation of these cells in vivo may improve upon the therapeutic results of future 
treatments. 
 
Enthesis: Hh cells at the tendon bone junction 
The attachment of tendon to bone at both the muscle origin and insertion occur at an 
interface called the enthesis that comprises of fibrocartilaginous tissue. A mineralized 
gradient exist at the enthesis, with tissue characteristics of increasingly more 
fibrocartilage quality moving distally towards the bone. During development, 
mineralization of the enthesis, mediated by Hedgehog (Hh) signaling occurs initially at 
the base of this structure and then extends towards the tendon midsubstance. The cells 
which maintain this fibrocartilaginous region appear to be hedgehog-responsive cells 
which react in response to a loading environment during development. Experimental 
ablation of Hh cells in a murine enthesis model, demonstrated a significant loss of 
mineralized fibrocartilage at the enthesis. It appears that this loss of mineralized 
fibrocartilage is due to the modified differentiation of enthesis progenitor cells (Schwartz 
et al., 2015). 
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Understanding the variable biology that occurs along the length of the tendon structure is 
important in guiding future research and in informing future clinical strategies. Tendon 
disease and rupture could occur at any location along the length of the tendon. For 
example, tendon defects at the midsubstance should be reconstituted primarily with dense 
regular connective tissue (and the protein/cells that entails), while disease or injuries near 
the enthesis however would ideally require a healing response that produces that natural 
gradient of fibrocartilaginous tissue as in a healthy tendon (Figure 2).  
 
Figure 2. Tendon Bone Interface, Toluidine Blue and Von Kossa Staining 
 
 
FC: Fibrocartilage 
NFC: Non-mineralized Fibrocartilage 
MFC: Mineralized Fibrocartilage 
 
A general gradient of fibrocartilage tissues exist  
at the bone tendon junction. The enthesis is characterized  
by spherical shaped tenocytes and cartilage producing  
chondrocytes near the bone insertion site. 
(Taken from Qu et al., 2015) 
 
 
Progenitor cells that differentiate into the fibrocartilaginous tissue of the tendon enthesis 
consist of hedgehog-active Gli1+ cells. Cell populations, in immature injured enthesis, 
display high levels of Gli1 expression and show good capacity to heal. This property, 
however, was lost after mature differentiation of these cells into fibrochondrocytes. It was 
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observed that injured mature enthesis had less Gli1+ cells in the healing process, thus 
explaining the limited healing of these tendons (Schwartz et al., 2017). These results 
suggest that utilizing key aspects in the natural developmental process as a primary 
strategy could be promising when devising improved tendon treatments in the future. In 
this case, the focus on Gli1+ expression and the targeting of such cells could be beneficial 
to positively stimulate healing at the tendon enthesis. 
 
Collagen Fibrils in the Tendon 
Structurally, the tendon tissue obtains its mechanical strength from the parallel 
arrangement of collagen fibers that run along the muscle bone axis. The tendon comprises 
a hierarchy of fibrillar structures, consisting primarily of triple helical type I collagen, 
which bundle to form fibers, fascicles and ultimately bundle to form the entire tendon 
unit (Figure 3). Each collagen molecule begins with synthesis within the cell, followed 
by the helical assembly of three collagen molecules. After secretion from cells, cleavage 
of procollagen at the N and C terminal produces what’s known as a tropocollagen. These 
tropocollagen molecules then interact laterally and undergo deamination of various lysine 
and hydoxylysine residues, stabilizing the collagen fibril through cross link formation 
(Kadler et al., 1996).  
 
When viewed under the microscope, tendons have a characteristic wavy pattern, known 
as crimps that represent an inherent extensibility of collagen fibers in the un-stretched 
tendon. In addition to fibrillar collagen, the tendon consists of various other ECM 
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molecules in association with the fibers including elastin, proteoglycans, 
glycosaminoglycan and glycoproteins. Glycosaminoglycans (GAG) are long polar 
polysaccharide molecule of repeating disaccharide units. Because of the highly polar 
nature of GAGs, hydration contributes to the volume of tendinous tissue and provides the 
necessary viscoelastic properties required in muscle force transmission, and mechanical 
support.  
 
 
 
 
 
 
 
 
 
Figure 3. Hierarchial Structure of the Tendon 
The structure of tendon is made up of a hierarchical arrangement of collagen fibers. Collagen fibers 
assemble into triple helix structures, which combine lateral and longitudinally to form microfibrils. These 
microfibrils combine into fibrils, fibers. Tenocytes are fibroblast like cells which contribute to collagen 
production and maintenance of the extracellular matrix. (Adapted from Killian ML et al, 2012)..  
During movement, each fascicle of collagen fibers move relative one another and this 
arrangement allows for the tendon to change shape as the muscles contract. The 
endotenon is a connective tissue layer present between each fascicle or fiber bundle and 
allows for facilitated sliding of tendon fascicles and fibers alongside one another (Figure 
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4) (Kastelic et al., 1978). Fascicles and collagen fibers slide alongside one another with 
ease in a proteoglycan rich matrix, which interestingly contains molecules such as 
lubricin, a molecule associated also with joint lubrication (Sun et al., 2000).  
 
Vascular Supply in Tendons 
Compared to other tissues in the body, tendons have a vascular supply notably less than 
that of other metabolically active tissues such as muscles. Vessels usually enter tendons 
at the myotendinous junction and while poorly vascularized, the vascular supply in 
tendons are important in providing nutrients and maintaining the activity of tendon cells. 
Adjacent tissues such as the tendon sheath or associated adipose tissue generally receive 
greater blood flow than the neighboring tendon. During physical activity, peritendinous 
tissues receive an increased blood supply (Langberg et al., 1998), and this local increase 
may be indirectly beneficial to the neighboring tendon tissue. Such observation may be 
grounds for supporting the use of moderate exercise in the therapy of tendon injuries or  
to improve blood flow in various tissues.  
 
In some tendon areas however, there is a very stark avascularity contributed possibly by 
the absence of VEGF (Petersen et al., 2002) and/or elevated levels of endostatin (Pufe et 
al., 2003). Such avascularity almost certainly contributes to the limited healing capacity 
of tendinous tissues, and thus should discourage development of therapies which rely 
primarily on delivery through the systemic circulation. Instead, therapies focused on local 
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delivery of factors which improve healing will likely be the key for future tendon 
treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Longitudinal and Transverse Histological Section of Tendon 
Endotenon sheaths the collagen fascicles and are important in allowing fascicles to slide within one 
another. CF: Collagen Fibrils, TC: Tendon Cells, E: Endotenon, FA: Fascicles (Taken from Benjamin et al., 
2000) 
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MOLECULAR CHARACTERISTICS OF TENDONS 
While tenocytes typically exhibit less metabolic activity overall when compared to other 
cells, there is still a great deal of molecular activity occurring in the mechanically passive 
tendon tissue as a whole. An understanding of the molecular underpinnings which occur 
at the cellular level becomes crucial in identifying targets for clinical therapy. As 
signaling cascades are better teased out and their impact on tendon function sorted out, 
strategies for clinical treatment can then be better focused and devised.  
 
Tendon Transcription Factors 
In the tendon, the best described transcription factors to date involved in tendon 
formation include, scleraxis, Mohawk and EGR1/2. Scleraxis is a basic helix-loop-helix 
transcription factor that appears to be important in collagen fibrillogenesis. EGR, a more 
recently identified transcription factor playing a role in tendon formation, appears to 
regulate expression of scleraxis and various collagen genes commonly associated with 
tendons. Many investigations have described the function of these transcription factors in 
the context of mechanotransduction, gene regulation and cellular signaling.  
 
Scleraxis 
Notably, scx null mice exhibit reduced expression of Col1a1 and a complete loss of 
Col14a1 and Tnmd. Functionally, these mice exhibit a decline in the use of various 
muscles of the paws and back due to the loss of tendon functionality. Overall, the 
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transmitting force of tendons was greatly affected; however tendons responsible for 
anchoring muscles to bones were mostly intact (Murchinson et al., 2007).  
 
In fetal equine tenocytes, knockdown of scleraxis expression using shSCX (short hairpin 
RNA) significantly reduced the expression of scx. Subsequently, this knockdown of 
scleraxis led to reduced expression of col1a1, COMP, and sox9 expression. Furthermore, 
generation of artificial tendon from fetal tenocytes or equine ESCs lacking scx expression 
failed to contract the matrix, however, a similar knockdown culture with adult tenocytes, 
yielded no significant difference when compared to control. This may demonstrate that 
normal function of adult tenocytes, while expressing scleraxis, does not require scleraxis. 
Interestingly, tendons grown from fetal tenocytes survived poorly in 3D culture, despite 
improved survival in a 2D environment. This suggests that in the developing tendon, scx 
may have an important role in the organization of the matrix. Fetal tenocytes grown with 
shSCX exhibited reduced expression of col1a1. Consistent with this, an overexpression 
of SCX in knockdown cells was able to rescue the col1a1expression back to normal 
levels (Bavin et al., 2017). 
 
Ectopic expression of scx in human MSC led to the increased expression of tendon genes 
such as collagen type 1, decorin, fibromodulin and tenomodulin. MSCs were able to 
transform into tendon progenitors when lentiviral vectors containing the scx gene were 
introduction by transduction. This transformation was characterized by reduced 
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proliferation and clonogenicity and the failure to differentiate into chondrocytes and 
osteoblasts. (Alberton et al., 2011).   
 
EGR 
In chick embryos, during development increasing expression of Col1a1, Col3a1 and 
Col14a1 and the transcription factors Egr1 and Egr2 followed a similar time course, 
suggesting that Egr1/2 may be responsible for regulating expression of collagen. 
Additionally, very much like how FGF-4 positively regulates scleraxis and tenascin in 
chick limbs during development (Vovard et al., 2002), in situ hybridization identifies that 
FGF-4 beads introduced into chick limbs positively regulates the expression of Egr1/2 
and the various tendon collagens. Mutant Egr1/2 mouse exhibit reduced levels of Col1a1 
transcript and reduced collagen fiber density (Figure 5). Finally, chromatin 
immunoprecipitation experiments identify that Egr1 but not Egr2 interact with tendon 
regulatory regions of the Col1a1 proximal promoter. Together these results, illustrate 
Egr1 role as a DNA binding protein and its involvement in the regulation of tendon 
differentiation in mouse and chick (Lejard et al., 2011). 
 
Furthermore EGR1 appears to be a mechanosensitive transcription factor,  illustrated by 
the fact that 3-D engineered tendons and adult tendons deprived of mechanical signals  
exhibit redueced express ion of Egr1 and tendon related genes . Converseley, Egr1 
overexprsession prevents tendon gene downregulating in the mechanically deprived 
tendon. These results identify Egr1 as a mechanoresponsive transcription factor 
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regulating the epression of tendon genes in response mechanica signals. The significance 
of Egr1 clinically may include utilizing targeted upregulation of Egr1 in mechanically 
deprived tissues to improve a healing response (Gaut et al., 2016). 
 
 
 
 
 
 
 
 
 
 
Figure 5. Egr1/2 mutants exhibit decreased collagen fibril densities. 
Mouse mutant exhibit reduced collagen fibril densities. The effect is significant in both Egr1 and Egr2 
mutants. (Taken from Lejard et al., 2011) 
 
Tenomodulin and tenogenic differentiation 
Tenomodulin is a tendon specific gene marker that appears to be important in tendon 
maturation. Its expression is found in skeletal tendons, ligaments as well as in chordae 
tendineae cordis of the heart. A type II transmembrane glycoprotein, tenomodulin (tnmd) 
possesses an intracellular C domain that likely operates as the functional domain. 
Investigators observed no severe phenotype in a tnmd KO mouse model, however, tendon 
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cell density and proliferation appeared to be reduced.  Achilles tendon from tnmd 
deficient mice, displayed increased fibril diameter similar to that seen in aged tendon. No 
effect on extracellular matrix protein levels was observed in  tnmd deficienct tendon 
(Docheva et al., 2005). These observations support the notion that tenomodulin plays a 
role in tenocyte proliferation, and the regulation of collagen organization but less of a 
role in regulating expression of non-collagenous matrix proteins.  Like scx, tenomodulin 
is a marker of tendon, and it has been demonstrated that there are relatable expression 
changes in the other when scx or tnmd expression is altered. Specifically, overexpression 
of scx in chicken tenocytes led to the upregulation of tnmd expression (Shukunami et al., 
2006). Similarly, scx KO mice exhibited a decrease in tnmd expression.  
 
Plasma mediated overexpression of tnmd in a murine embryonic cell line significantly 
enhanced cell proliferation and the expression of tenogenic molecules including scx, 
collagen type 1,3,6 and decorin. Additionally, the murine mesenchymal stem cells were 
inhibited in their ability to differentiate into adipogenic, chondrogenic and osteogenic 
lineages. The inhibited expression of non-tenogenic markers and the upregulated 
expression of tenogenic genes lend further support that tenomodulin has important 
influence on various aspects of cellular response in tendon cells (Jiang et al., 2016).  
 
 Loss of tenomodulin in mouse TSPC (tendon stem/progenitor cells) exhibit decreased 
proliferative potential as illustrated by increased expression of p53, and lower cyclin d1 
levels. Furthermore, the proliferative deficit of tendon tnmd KO TSPCs is rescued 
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following transfection by Tnmd cDNA suggesting a role of tnmd in the cell’s self-
renewal ability (Alberton et al., 2015). Furthermore, other groups have demonstrated that 
tnmd is an angiogenic inhibitors and may contribute to the general hypovascularity of the 
tendon (Oshima et al., 2004).  
 
Tenomodulin deficient mice exhibit decrease Achilles tendon tenocyte cell density at 
1and 6 month old compared to wild type mice. This decrease in tenocyte cell density 
was attributed to a decrease in cell proliferation and thus suggests tenomodulin plays an 
important role in tenocyte proliferation (Docheva et al., 2005). A reduction in cell 
proliferation has also been observed in patellar tendon from Tnmd knock out mice (Qi et 
al., 2012). 
 
Expression analysis of Achilles, patellar, and rotator cuff tendons of 1 week old rabbits, 
identify distinct tenomodulin and chrondromodulin positive cells at the bone attachment 
site. The tenomodulin cells co-expressed type I collagen whereas more distally the cells 
co expressed chronomodulin and type II collagen, as expected. However, between these 
two cell groups was yet another distinct cell group characterized by only the expression 
of type I collagen without tenomodulin. Furthermore, red blood cells are identified 
exclusively at this interface where these transitional cells are found. This sheds light on 
the possibility that while tenomodulin appears to have many influences in the developing 
tendon, a separate population of transitional cells exist that may facilitate angiogenesis to 
occur (Yukata et al., 2010). In a hypovascular tissue like the tendon, where access to 
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nutrients is limited, identifying an area where vascular tissue might proliferate could be 
truly vital to the development of future therapies. 
 
Tenomodulin and scleraxis are probably the most well described of the tendon markers. 
While the cellular expression patterns that occur upon manipulation of tnmd and scx in 
the developing tendon have been described, what these molecular changes mean in terms 
of mechanical functionality in the adult is unclear. Further investigations to identify the 
mechanical consequences due to ablation of tnmd or scx expression in adult animal 
models will allow researchers to more confidently identify a role of scx and tnmd beyond 
just a developmental regulator and marker of tendon. Tnmd overexpression in in vitro 
human PDL cells exhibit increased cell adhesion to ECM whereas in vitro tnmd KO mice 
fibroblasts show decreased cell adhesion. This cell adhesion may be important in 
strengthening the mechanotransduction ability of cell-ECM connections in the PDL 
(Komiyama et al., 2013). Likewise, it is possible that such mechanisms underlying tnmd 
manipulation may occur in various tendons of the body as well. 
 
Extracellular Components 
In addition to fibrillar collagen and the intracellular and membrane components of the 
cell playing a crucial role in tendon function, various extracellular components secreted 
by the cell also functional vitally in maintaining the function of the tendon . These 
extracellular components interact with fibrillar collagen and mediate interaction between 
the ECM and the tendon cells. Like many factors in tendon, these molecules exhibit 
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responsiveness to mechanical changes in the tendon. These extracellular glyocproteins 
and glycoasminoglycans exhibit variable localization and expression patterns that 
represent a response to the mechanical environment of the tendon. 
 
Tenascin C mediates tenocyte-matrix interactions 
In comparison to expression of type 1 collagen and type 3 collagen, TN-C expression 
correlates highly with tendon specific characteristics and thus better suited as a marker in 
identifying tendon cells. Tenascin C expression is observed at regions of tissues which 
undergo high mechanical forces such as at the myotendinous and osteotendinous 
junctions (Chevalier et al., 1994; Mackie et al., 1996).  
 
Tenascin C is an ECM glycoprotein initially discovered at the myotendinous junction. 
Tenascin C belongs to a class of matricellular proteins whose function is to modulate 
cell-matrix interactions (Murphy-Ulrich, 2001). Evidence suggests that tenascin-C 
possess elastic properties and can physically be stretched to several times the resting 
length. Atomic-force-microscopy demonstrates that fibronectin type III domains of 
tenascin possess an extensibility that could be stretched after application of a force, and 
re-folded when the force was reduced (Oberhauser et al., 1998). These results suggest a 
mechanical function for the protein, particularly in tendons, where its expression is 
prevalent.  
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In stressed collagen gels containing fibroblasts, tenascin C expression is observed to be 
elevated, suggesting a role in response to mechanical stimuli (Chiquet-Ehrismann et al., 
1994). Consistent with its role in response to mechanical stimuli, in an in vitro cell 
scratch culture, tendon cells exhibit a significant increase in tenascin-C mRNA 
expression at 12 hr after scratching. This expression increase was concomitant with 
regeneration of the cell sheet and thus suggests that tenascin may have a function in 
tendon wound healing (Nemoto et al., 2013).  
 
Furthermore, a study of variable mechanical loading on rat gastrocnemius muscles indeed 
demonstrate a change in expression of tenascin-C in response to mechanical stimulus. 
When load stimulus increased, tenascin C expression increased at the myotendinous 
junction, and within the tendinous tissue. Rats put in a cast demonstrate much lower 
expression of tenascin-C. This expression could be rescued when casts were removed and 
a strenuous mechanical stimulus applied for 8 weeks. Tenascin-C while expressed at the 
myotendinous and myofascial junctions and directly in the tendon could not be induced 
to be expressed in the skeletal muscles (Jarvinen et al., 2003). These results suggest the 
cellular response of tenascin C to mechanical stimulus but also suggest that tenascin C 
could be useful as a marker distinguishing cells of tendon origin from muscle. 
 
Decorin regulates fibril diameter 
Decorin is a leucine rich proteoglycan which appear to be involved in regulating collagen 
fibril diameter. Decorin has been shown to bind non-covalently to the surface of various 
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fibrillar collagens and generally slows the rate of fibrillogenesis (Vogel et al., 1994). The 
side chain of decorin extends laterally and appears to be responsible for maintaining 
interfibrillar spacing between collagen fibrils (Scott et al., 1998).  
 
Decorin deficient mice exhibit lateral fusion of collagen fibrils and thus reinforce the 
concept that decorin plays a role in maintaining collagen fibril spacing and preventing 
lateral fusion (Danielson et al., 1997). In TEM scans of horse digital flexor tendons, 
differences in collagen fibril diameters correlated with the amount of decorin. In the 
distal metacarpal, where density of collagen fibrils was greatly reduced, decorin was 
observed to be the greatest in this region and thus suggesting decorin’s influence on 
collagen assembly (Watanabe et al., 2005).   
 
While often described alongside its effects on retarding fibrillogenesis, some studies 
show a somewhat different relationship between decorin and its ability to influence 
collagen fibrillogenesis. In one study, mouse patellar tendons were evaluated for various 
mechanical qualities and decorin null tendons were observed to have a significantly 
decreased fibril diameter compared to average. This is counter to the other studies 
mentioned above, which suggest in decorin KO animals, lateral fusion should occur. 
Regardless, together these observations suggest that decorin has some kind of significant 
influence on fibril assembly (Dourte et al., 2012). 
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Other studies have revealed decorins contribution to age related changes in tendon 
structure and mechanical function. Interestingly, decorin null tendons exhibit 
significantly less age related changes than wild type tendons. Histological analysis 
demonstrates that decorin and biglycan null tendons do not observe the typical decrease 
in fiber alignment observed in wild type tendons. (Dunkman et al., 2013). Together these 
results suggest that the normal process of aging in tendon correlates highly with the 
presence of decorin expression. With age, tendons exhibit many changes which affect 
overall function, including loss of biomechanical strength and increased stiffness. 
Because of aging these tendons become more susceptible to disease and/or injury, and 
thus these findings suggests that decorin may be the physical cause of reduced 
mechanical function in aged tendons and a potential target for future therapies. 
 
Aggrecan responds to compressive forces 
Aggrecan is a large chondroitin-sulfate proteoglycan which has been well described to 
play a role in compressive loading of cartilage. Aggrecan contains many GAGs, with 
negative polysaccharide chains and thus provide an optimal environment for water 
recruitment and resistance to compressive forces in cartilage (Watanabe et al., 1998). In 
tendon, some studies have similarly demonstrated aggrecan to be upregulated upon 
compressive loading of the tendon tissue (Robbins et al., 1997).  
 
In human supraspinatus tendon, Aggrecan has been shown to exhibit regional variability, 
with increased expression in anterior and posterior regions and reduced levels in the 
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medial regions of the tendon. Some researchers interpret this as indicating that Aggrecan 
is preferentially upregulated in areas required to sustain greater compressive forces 
(Matuszewski et al., 2012). In a model of Achilles tendinopathy, tendon samples of 
painful tendinopathies exhibited greater expression of aggrecan and biglycan mRNA, 
suggesting a response to an altered mechanical environment (Corps et al., 2006). 
Together, these results suggest that aggrecan plays an important role as a proteoglycan in 
mediating the responses to compressive forces. 
 
Often the focus of tendon functionality revolves around its ability to withstand tensile 
forces, but equally prevalent superficial tendons or tendons passing over convex surfaces, 
must also be able to withstand compressive forces. Aggrecan appears to correlate with 
changes in compressive mechanical stimuli, and understanding Aggrecan role may yet be 
another factor that could be targeted to ensure that the proper strength of tendons is 
reached during the tendon healing process. 
 
BIOMECHANICAL BEHAVIOR OF TENDONS 
Tendons exhibit non-linear and time dependent mechanical behaviors with a distinct toe, 
linear and failure region (Figure 5). The toe region represents the most compliant portion 
of the curve, where low loads on tendon leads to greater elongation. This toe region 
represents a low amount of stress needed to straighten out the crimp pattern of collagen. 
The linear region represents the stretching of collagen fibrils where further loading causes 
increases in resistance to stretching (greater stiffness). In the linear region, when tensile 
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force is released, the tendon returns to its original length and shape eventually. In the 
failure region, as load increases, stiffness increases briefly until damage to the tendon 
occurs and further loading encounters reduced or no resistance. Release of tensile forces 
does not cause return of the tendon to original length. 
 
Under different loading conditions such as differing loading rates, mechanical response 
differs.  Under greater loading rates, tendons exhibit increased failure stress and failure 
strain. Tendons usually operate at about 30-40 percent of the ultimate tensile strength 
(UTS). Compared to normal tendons, tendons that rupture more easily such as that in the 
Achilles and Quadriceps tendon exhibit smaller collagen fibres with lower crimp angle. 
Differences in collagen fibrils diameters in a study looking at human tendons demonstrate 
36% and 24% and 37% reduction in the Achilles, quadriceps and biceps brachii tendons 
compared to healthy tendons. (Jarvinen et al., 2004)  
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Figure 6. Strain, Stress Curve. Toe, Linear, Failure Curve for tendons (taken from 
Mienaltowski et all., 2014) 
The Stress-strain curve identifies three unique regions of biomechanical behavior exhibited by the tendon 
tissue. The initial toe region exhibits greater elongation under lower loads because of the extensibility of 
the collagen crimps. 
 
As a tissue responsible for mechanical transmission, understanding the physical and 
molecular response of tendinous tissue to mechanical forces is undoubtedly important in 
guiding clinical treatment and to establish useful assessments for evaluating tendon 
function. Generally, it is suspected and known that tendinous tissue increase tensile 
strength and stiffness in response to mechanical loading (Woo et al., 1980).  In a study of 
rabbit tibialis posterior and Achilles tendon, 40 weeks on a running machine led to 
increases in stiffness of approximately 10 percent and a tensile strength increase of 
approximately 5 percent (Viidik, 1967).  
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Interestingly the increase in tensile strength does not necessarily appear to be due to an 
increased expression of collagen. Despite being the predominant substance encompassing 
the majority of the tendon’s dry weight, some investigations demonstrate that the amount 
of collagen does not seem to be directly related to a tendon’s tensile strength or stiffness.  
 
Rather, it appears that the cross links that hold together adjacent collagen molecules 
appears to be most critical to mechanical strength. Indeed, one study demonstrated a 
direct relation between the amount of cross linking and the tensile strength in rat patellar 
tendon (Chan et al., 1998). Microdialysis measurements of loaded tendons suggest that an 
acute adaptation by tendons lead to an increase in cross sectional area. Furthermore, 
studies have demonstrated that acute exercise leads to the increased formation of type I 
collagen in the peritendinous regions.  
 
Important to note however that is while the collagen fibrils are the main components 
undergoing strain in the tendon, the deformation in the overall tendon, is almost always 
greater than the cumulative strain in individual fibrils, suggesting that elements outside of 
the collagen fibrils also become deformed under the applied force. Studies which study 
changes in strain rate show that increased strain rate, caused a greater ratio in fibril strain 
to whole tendon strain.  
Collagens treated with aminoproprionitrile exhibit compromised cross-linking, and this 
dramatically reduced the tendon fracture load, suggesting that the mechanical properties 
of tendon relies heavily on the cross linking between the collagen fibrils. Normal 
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untreated collagens can withstand tensile forces of 120 MPa, whereas the average 
maximum stress in B-APN treated collagen falls precipitously to 15MPa (Figure 6). 
(Puxkandl et al., 2002). These results overall suggest that the mechanical strength of 
tendons come from the cross links, and while the fibrils are the ones directly being 
stretched longitudinally, the cross links afford some kind of additional bulk and stiffness 
and strength to the tendons. Perhaps future clinical treatments will require a primary 
strategy that strengthens cross links between collagen fibers and other ECM components 
in the healing tendon. 
Figure 7. B-APN treated collagen fibrils, Stress vs Strain Curves 
 
 
 
 
 
 
 
 
 
a) Normal force region in normal untreated tendon occurs around 120 MPa b) In B-APN treated tendon, 
normal force ranges occur around 15 MPa. (Adapted from Puxkandl et al., 2002) 
Elastic Recoil Energy in Tendon 
Structurally, collagen fibrils within the tendon produce a wavy pattern or undulating 
pattern due to the un-strained nature of the collagen fibrils (Figure 7). The crimps 
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represent a margin of longitudinal freedom that during contraction of muscle leads to 
stretching of these crimp and storage of elastic energy in the tendons. The crimp pattern 
is more disturbed in ruptured tendons and large variation in wave angle is highly 
prevalent. This decrease in crimp angle found within rupture tendon may explain their 
greater tendency to rupture. Similarly, decreases in mechanical loading over time seem 
lead to the straightening of these crimps, and may present conversion into a less 
mechanically effectual tissue (Jarvinen et al., 2004). Crimping in tendon may represent 
the inherent flexibility of the tendon and thus lower crimp angles along with thinner 
fibrils contribute to why some tendons are more susceptible to rupture.  
 
Figure 8. Tendon Crimp 
 
Tendons exhibit an inherent crimp along the collagen fibrils. The crimp represents relaxation along the 
longitudinal direction in the relaxed or a tendon under minimal tension. (Adapted from Lavagnino et al., 2016) 
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Crimp numbers may decrease nearly 50 percent when tendons are stretched in vivo 
(Franchi et al., 2007). This is important as it allows forces to be generated more 
economically. For example, during jumping when the muscle contracts’, stretching of the 
quadriceps tendon allows initial storage of energy and the release of that energy at the 
time of the jump. During jumping the tendon is stretched about 6% in the first 350 ms of 
the movement and only in the latter 100ms is the muscle tendon unit shortened. During 
this shortening phase, the released store elastic energy adds force to the jump (Kurokawa 
et al., 2001). In the Achilles tendon an average of 38 J or energy is achieved by this 
elastic stretch, contributing as much as 16% of the total mechanical work in a one legged 
hop (Lichtwark et al., 2005) 
 
Mechanical Behavior in non-collagenous tissues of the tendon 
The biological response of the ECM to mechanical loading may also rely on the ability of 
proteoglycans with extensive side chains to bind growth factors and present these factors 
to their relevant receptors on tendon cells in response to a mechanical stimulus. 
Understanding the mechanical link between the ECM substances and the specific cell 
populations are key to better teasing apart the molecular machinery that functions 
critically in maintaining a strong healthy tendon.  
 
Proteoglycans and non-collagenous proteins are thought to play an important role in the 
viscoelastic properties of tendon. Investigations comparing Decorin KO and control show 
that decorin KO mice tendons were less strain rate sensitive. Compared to mature tendon, 
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immature tendons have greater decorin content and exhibit inferior elastic properties but 
higher strain rate sensitivity. Tendon extracted from collagen accumulation transgenic 
mice and collagen reduction transgenic mice exhibited greater modulus and a reduced 
ability to withstand a maximum load. Together these data highlight the importance of 
non-collagenous elements of the ECM in tendon loading. (Robinson et al., 2004).  
 
In ligaments, a tissue structurally similar to tendons, inhibition of decorin with antisense 
therapy results in large collagen fibrils and increased mechanical strength (Nakamura et 
al., 2000). It is possible identical treatment to tendon would reveal a similar effect.  
As a tissue under frequent load bearing, tendon homeostasis understandably relies on 
mechanical loading. Changes in loading evoke a response of cells at the molecular level 
which affect the tissue as a whole. Such loading, causes cells of the tendon to increase 
expression of growth factors, expression of receptors, activity of cell metabolism and 
matrix turnover. Cytoskeletal elements within cells mediate the transmission of 
mechanical loads and lead to changes in cell signaling.  
 
Stress deprivation upregulates MMP13 expression and a gradual loss of cell to matrix 
contact. Fresh tendons loaded under 1% mechanical strain exhibited a reduction in 
mRNA expression of MMP13. To rescue stress deprived tendons, strain needed to be 
increased at least up to 3% to achieve that same level of inhibition. These results 
demonstrate the fine importance of mechanical stimulation and tendon homeostasis 
(Arnoczky et al., 2008) 
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As mentioned above, non-collagenous substances in the ECM can undergo deformation 
in response to stress. Such responses alongside collagen fibrils, while not the primary 
tissues involved in transmission of skeletal forces, suggest that they may be important in 
facilitating the mechanical sliding of collagen fibrils, and the transduction of mechanical 
stimulus into cellular responses within tenocytes.   
 
Cellular Responses mediated by mechanical Stimuli  
One study, demonstrates that tendon cells under load are attached through an actin based 
cell-cell interaction that is aligned in the direction of stress. Under load, they attach more 
strongly, and assemble more of their actin fibers with tropomyosin, suggesting an active 
use of SMA in contributing to the tensile strength of tendon and maintaining cell-cell 
adhesion. It is likely these SMA are involved in maintaining contacts between tenocytes 
and thus involved in ensuring transmission of signals between cells evoked by 
mechanotransduction (Ralphs et al., 2002).  
 
When tendons undergo tensional forces signal passing through gap junctions allow 
intercellular communication to commence an appropriate cellular response to the 
mechanical stimulus. In vitro, tenocytes increase the expression of collagen synthesis 
when subjected to tensional forces and treatment of tendons with anti-gap junction agents 
(such as halothane, gap27 and antisense) demonstrate a significant effect of the collagen 
response. Specific downregulation of connexin-32 or connexin 43 caused differential 
responses. Signaling through connexin 32 relays a stimulatory response of collagen 
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synthesis and connexin 43 relays an inhibitory response of collagen synthesis (Waggett et 
al., 2006). 
 
It may be an important point here to consider that perhaps the long term loss of tendon 
function following trauma or disease, while due to loss of mechanical strength, may be 
underpinned by a loss of effective cellular signaling caused by overbearing stresses. 
Whether SMA, gap junctions, or other ECM components are integral to effective 
mechanotransduction is unclear. If tenocytes become ineffective in their communication 
and lose mechanotransduction ability, then complete healing may be hindered, and focal 
regions of weakened and ineffective tissue may be observed.  
 
TENDON PATHOLOGY 
Tendons exhibit a variety of pathologies ranging from overuse and age-related 
degeneration. Certain tendons are more susceptible to pathology than others, and include 
tendons which lie more superficially and thus subjected to more direct trauma. Tendons 
that exhibit greater forces or greater duration of use such as the rotator cuff, Achilles, 
tibialis posterior and patellar tendons also exhibit more frequent pathologies due to the 
nature of overuse.  In tendons like the rotator cuff, there have been reports that as much 
as 15 percent of the population will suffer from some kind of rotator cuff shoulder pain. 
When considering the elderly or hospital population, this number rises above 20% 
(Urwin et al., 1998).  
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Tendon Pathology Continuum 
There exist in the literature some attempts in trying to describe the stages of tendon 
pathology. One framework describes an initial acute tendon response, a rapid response 
where loading of the tissue increases tendon volume and water. Following, there exist 
tendon disrepair, which is a response characterized by increased proteoglycan expression, 
collagen disorganization and various vascular changes.  In this stage, imaging 
demonstrates increased matrix disorganization, with small focal areas of hypo-
echogenicity. The next stage, degenerative tendinopathy, is probably the best described in 
the literature and is described by areas of cell of death due to apoptosis. Acellularity is 
markedly obvious along with extensive areas of matrix disorganization, and reduced 
amount of collagen.  While these stages may imply a progression of tendon pathology, 
evidence exists that suggests tendon conditions can progress between these stages in 
either direction (Cook et al., 2009) (Figure 8).  
 
In a study of young basketball athletes, imaging of tendon which experience a long 
period of high tendon load displayed reactive tendinopathy. In longitudinal imaging 
studies, 10-30 percent of tendons which appeared to be abnormal at baseline became 
normal on follow up imaging time points (Cook et al., 2000). This suggests that, at least 
for tendons reaching reactive tendinopathy stage, reversal back into a state where 
imaging cannot distinguish from normal tendon is still possible.  
 
 
 34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Tendon Pathology Continuum 
Tendon pathology occurs on a continuum and at some stages there is potential to revert to an earlier stage. 
Specifically, patients in reactive tendinopathy have potential to revert to a stage of normal tendon structure. 
(Taken from Cook et al., 2008) 
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1Age Related Decline in Tendon 
Pathologies of tendon not only occur due to overuse and acute trauma but also natural 
declines occur due to aging. Many studies describe a notable mechanical decline occurs 
in tendons due to age. However, the nature of these declines biomechanically may be due 
to several reasons, such as changes in fibril diameter, matrix organization or collagen 
type. In one study, investigators observe in rabbit tendons a decline stress of 25% 
between 1 and 4 years of age. 4 year old rabbits showed smaller fibril diameters than 
compared to 1 year old rabbits, and this correlated with the presence of type 5 collagen 
only in the 4 year old rabbit tendons. Mechanical property changes in age appear to be 
due to both changes in the type of collagen which in turn lead to smaller fibril diameters 
(Dressler et al., 2002) (Figure 9) (Figure 10).  
 
TREATMENT OF TENDON DISEASE, INJURY AND PATHOLOGY 
Treatments of tendon pathologies often include much more conservative treatments such 
as load reduction and certain pharmacotherapies. The utility of stage classification for 
tendon pathology may allow the categorization and selection of effective therapies. For 
example, for tendons exhibiting signs of early reactive tendinopathy or early tendon 
disrepair, modifying load/reducing load may be the most important as it allows the cells 
to become less reactive and revert to a normal structure. 
 
 Pharmacologically, NSAIDs limit the ability of tendon repair, however such limitation 
may be desirable as upregulation by tenocytes, and of ground substance expression are 
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apparent in this phase. Ibuprofen and other drugs, also have an effect in downregulation 
of a cellular response, and thus may be superior to NSAIDs as these also do not seem to 
have a negative effect on tendon repair (Ferry et al., 2007).   
 
 
 
 
 
Figure 10. Fibril diameter in 1 year old and 4 year old rabbit tendons 
There is a general distribution of smaller diameter fibrils in the 4 year old rabbits compared to 1 year old 
rabbits. 
(Taken from Dressler et al., 2002) 
 
In the following stage of late tendon disrepair/ early degenerative tendinopathies the goal 
to treatment runs counter to the previous stage and that is to upregulate and stimulate the 
cells. Because of large hypoechoic areas, apoptosis and large areas of disorganization it is 
important that tendons be stimulated to produce more protein and to restructure the 
matrix effectively. Physical treatments include ESWT, frictions as well as ultrasound. All 
these modalities have been demonstrated to help with pain and to show various 
morphological and mechanical benefits.  Surgery has also been shown to be equally or 
less effective than the above modalities. Assessments of pain and evaluations of various 
performance metrics post-surgery showed no advantages compared to eccentric training 
in jumping athletes. Nevertheless, when the typical conservative treatments fail, surgery 
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is still the primary alternative utilized (Maier et al., 2002, Bahr et al., 2006,  Maffulli et 
al, 2006). 
 
 
 
 
 
 
 
Figure 11. Collagen Type Expression in 1 year and 4 year old rabbit tendons 
Lane 1-4, 1 year old tendons, exhibit the typical Type 3 and type 1 collagen. Lane 5-8, only 4 year old tendons 
express type 5 collagen. (Taken from Dressler et al., 2002) 
 
Various pharmacotherapies exist for the treatment of degenerative tendinopathy with the 
goal of stimulating tendon upregulation of a healing response. Prolotherapy using glucose 
and blood stimulate cell proliferation and production of VEGF, and has been 
demonstrated to positively induce matrix changes (Anitua et al., 2005).  
 
Challenges to Tendon Treatment 
Clinically, treatment of tendon injury or disease involves the use of suture, fibrin glue, 
bioactive agents (PRP, PC, PRGF, serum) and biological scaffolds. The repair of large 
tendon defects however conventionally utilizes grafts to repair tendon gaps and thus 
much investigation and effort has been put into tissue engineering strategies in order to 
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improve upon complications that often come with graft repair. In the case of autograft 
procedures this includes donor site morbidity, and risks of re-injury (Docheva et al., 
2005). Additionally, finding an autograft with characteristics similar to the original 
tendon can be difficult or impossible, and thus autograft repair can fall short of being a 
quality option for many clinical situations (Seiler et al., 1995).  As is the case with repair 
of the flexor tendons of the hand, the palmaris longus donor tendon is an extrasynovial 
tendon and if grafted to replace intrasynovial tendons such as the FDS or FDP, it is likely 
to cause complications such as scarring and adhesions. These scarring and adhesion lead 
to reduced mobility of the muscle-tendon unit. 
 
Synthetic Polymers 
Potential alternatives to autografts include allografts and the use of synthetic polymers. 
When it comes to allografts, immunogenicity of the donor tissue becomes a concern. One 
investigated method utilizes de-cellularized tendons from cadavers. This removes greatly 
the potential for immunogenicity of the graft, though some researchers demonstrate 
concern that these grafts lack the strength and biological capabilities to replace the 
original tendon. Thus some have proposed that allografts in order to mediate effective 
healing should be repopulated with cells when introduced at the defect site. Investigation 
of donor rabbit flexor tendon allografts repopulated with tenocytes showed survival up to 
12 weeks after surgery. At 30 weeks the cells of the recipient take over and repopulate 
the graft. These results suggest promise in allografts when the choice of auto-grafts 
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becomes burdened with complications such as shortage and morbidity (Thorfinn et al., 
2009). 
 
Treatment Complications: Adhesions 
Adhesion formation is a common complication associated with engraftment procedures, 
and thus the prevention of adhesion formation is also crucial for effective graft repair. 
Many studies have studied the use of modified allografts in the repair of tendon defects to 
observe if adhesion formation can be reduced. Adhesions are a complication that occurs 
in the repair of injuries of flexor tendons. These fibrotic lesions may complicate tendon 
gliding and limit the range of joint flexion. It is thought that the tendon fibrosis occurs 
due to the suturing or surgical manipulation which causes tenocytes necrosis and cause 
fibrotic lesions to overtake the remodeling of the tendon (Gelberman et al., 1985).  
Intrasynovial tendons on the other hand have a tendon lining and sheath that make it less 
prone to forming adhesions. Such observations would suggest the need to develop 
artificial grafts or prepare allografts which are similarly protective against adhesion and 
scar formation. The nature of these preparations is uncertain, and would require further 
investigation to identify the best strategy to do so. 
 
Tackling Adhesion and Fibrotic Tissue Formation 
Acellular Autografts 
Another investigation looking to tackle this issue used bovine flexor tendons and 
demonstrated that tendons repaired with acellular allografts exhibited minimal adhesion 
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and lesser thickening of tendon at the reconstructive site (Ramesh et al., 2003). Such a 
result may suggest then that an acellular allograft may be a more appropriate graft than 
the use of extrasynovial grafts, which are more likely to cause adhesions and excess 
scarring.   
 
 
 
 
 
 
 
 
 
 
Figure 12. Adhesion Scar Formation Autograft vs Acellular Allograft 
Scarring and fibrotic tissue formation is most evident in the autograft (A-C) especially when compared to 
acellular allograft (D-F), where scarring is only seen at the host – graft junction. * represents areas of scarring, 
G: graft tissue  Adapted from (Hasslun S et al, 2008) 
 
Other studies have shown similar results, such as a study which graded gliding and range 
of motion on a numerical scale when comparing live autografts and acellular revitalized 
allografts. In this study, neither graft afforded a gliding coefficient similar to normal 
tendons. However, histologically, the autograft was characterized by extensive 
remodeling and copious scarring at both ends of the graft. In the acellular allograft, 
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scarring was most notable at the graft-host junction but mildly in the mid body of the 
tendon graft even 28 days post grafting (Hasslund et al., 2008).  
 
Taken together, these observations suggest that the use of acellular grafts may be one 
viable strategy to tackle the issue of over scarring. However,given that fibrotic adhesions 
still form in moderate amounts, a superior strategy combined to or distinct approach is 
required for improved results (Figure 11). 
 
Anti-Scarring Adjuvants: 5-FU 
Other methods to reduce scarring and adhesion have been approached by other groups, 
such as the delivery of anti-scarring adjuvants to reduce the activity of TGF-β, a known 
scarring agent. In one study, rabbits treated with 5-FU at the tendon repair site led to a 
significant reduction in the inflammatory response mediated by a reduction in TGF-β 
activity (Khan et al., 2000). Similarly, targeting of TGF-β using antibodies or a synthetic 
inhibitor (CS-1 peptide) in rats led to a reduced immediate inflammatory response and 
reduced adhesion formation (Jorgensen et al., 2005). 
 
Coating Scaffolds: HAM, Periosteal Grafts 
Further strategies to tackle adhesion formation include the use of coating scaffolds or 
grafts in order to prevent fibrotic tissue formation and excess scarring. One such coat 
may include the use of Human amniotic membrane tissue. HAM does not express surface 
antigens and thus becomes viable for use as a coating sheath. Application of HAM and 
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HA in healing chicken tendons indeed has been shown to prevent the formation of 
peritendinous adhesions (Ozgenel et al.,, 2004). Rabbit FDF tendons wrapped in 
periosteal tissue also demonstrate a protective effect against adhesion formation. 
Periosteum synthesizes IGF-1 which additionally is beneficial as this factor is known to 
improve tendon healing (Mehta and Mass, 2005)  
 
The use of periosteal tissue as a means to improved tendon healing has received some 
attention in various studies due to the reasons beyond it’s protective effects against 
adhesion. Periosteum is a fibrous tissue that can generate collagen, and has been reported 
to improve ossification in ACL reconstruction (Lukas et al., 2007).  It is surmised that the 
mesenchymal cells within periosteal tissues would have the capacity to differentiate into 
fibroblast and that could have positive effects on tendon healing.  
 
A study looking at FDF tendon grafts compared the effects of a periosteal autograft and 
human amniotic membrane coating on tendon healing. In this study, periosteal autograft, 
or HAM FDF tendon autografts had their post-engraftment biomechanical strengths 
compared to one another and to control. Biomechanically, at week 6, the FDF tendons 
came out strongest in the group encased in periosteal autograft. (Ozboluk et al, 2010)  
  
cd-HA coated allografts 
In one study, dogs given allografts coated with carbodiimide-derivatized hyaluronic acid 
exhibit decreased adhesion formation during healing, seemingly through a mechanism of 
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reduced inflammation, reduced matrix deposition and scar formation but without 
alteration to the cellularity of the donor graft (Karabekmez et al., 2012). These results 
suggest coating a graft can reduce adhesion formation and because cellularity is not 
affected would not compromise tendon healing after graft placement (Figure 12).  
 
 
 
 
 
 
 
 
Figure 13. cd-HA Treated Grafts Exhibit Reduced Adhesion Formation 
Macroscopic demonstrate obvious adhesion formation in intrasynovial and extrasynovial grafts. cd-HA coated 
grafts exhibit very obvious improvement when compared to saline controls. (Taken from Karabekmez et al., 
2012) 
 
Peroneus longus tendon grafts from the hind paws of dogs, coated with cd-HA consisting 
of 1% hyaluronic acid, 10% gelatin, demonstrated gliding resistance significantly lower 
than that of tendon grafts soaked in saline solution, at 3 weeks and 6 weeks post grafting. 
Treatment with a carbodiimide derivatized hyaluronic acid gelatin polymer decreased the 
digital work of flexion and gliding resistance in this canine flexor tendon graft model in 
vivo. (Zhao et al., 2006) 
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Adhesion formation is a well-known complication that occurs due to the natural tendon 
healing process. While much work still needs to be done to identify the cells, factors and 
physical manipulation responsible for such excess scarring, the studies described above 
illustrate potential avenues of further investigation. 
 
Xenografts: SIS 
The use of Xenografts as donor tissues has received much attention lately in many 
systemic organs. In the clinical situation of tendon disease, xenografts would much more 
easily address the shortage and donor site morbidity issues presented by autografts. While 
the complication of rejection and immunogenicity still subsist as it does in same species 
allografts, research has demonstrated much promise anyway in the use of Xenografts for 
tendon repair. 
 
The identification that porcine small intestinal submucosa can be utilized as a 
decellularized collagen based matrix in the use of tendon repair has received much 
investigation lately. In particular, one investigation assessed the use of SIS as a graft 
material for tendon repair in canines. When SIS were grafted into intrasynovial flexor 
tendon, host cells infiltrated the matrix by 6 weeks, neovascularization and a wavy 
oriented tissue resembling tendon tissue subsequently developed. SIS also appear to 
release chemoattractant peptides following chemical degradation in vitro, which may 
help to attract BM derived cells during in vivo graft repair (Derwin et al., 2004). 
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Xenografts are limited by the potential of rejection, however, studies have identified that 
the vigorous response observed with acellular SIS is to be expected and is not a rejection 
reaction. Specifically, comparison between xenogenic, synogenic and SIS transplantation 
in mice demonstrate differences in the cytokine production of interferon –gamma and IL-
4. Xenogenic graft tissue in mice exhibited a strong interferon-gamma response and this 
suggests a TH1 mediated response which has been previously described to be involved in 
rejection (Zhai et al., 1999). Whereas syngeneic grafts exhibit a much reduced mRNA 
transcript level of IFN-y than mice grafted with xenografts tissue, as confirmed by RT-
PCR. SIS implanted mice similarly expressed a reduced IFN-y response when compared 
to grafts in the xenogeneic group. These results suggest that the immune response is 
primarily a remodeling reaction and not one indicative of rejection. Additionally, while 
SIS implanted mice exhibited an acute inflammatory response, the remodeled graft that 
was histologically indistinguishable from native tissue, again indicating that the graft was 
accepted. (Allman et al., 2001) 
 
In other studies utilizing SIS, GFP expression marrow derived cells were tracked to 
characterize the chemoattractant ability of SIS and the nature of the cells attracted to the 
graft scaffold. At 16 weeks in SIS-ECM mice, GFP expression cells migrated throughout 
the remodeled tendon, whereas the autologous tendon graft group showed almost no GFP 
signal within the tendon tissue. These results suggest that the SIS recruits bone marrow 
derived cells that likely participate in the remodeling process following repair (Zantop et 
al., 2006).  
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While use of SIS shows promise, other studies do identify complications of adhesion 
formation with SIS grafts (Derwin et al., 2004). Perhaps though, SIS grafts combined 
with some kind of coating or anti-scarring adjuvant could reduce the likelihood of 
adhesion formation assuming that the ability to attract BMSC due to coating is not lost.  
 
The use of autografts has its benefits, its shortage and the burden of donor site morbidity 
however makes this option less attractive. Additionally, with Xenografts there is concern 
that Xenografts may make recipient sites susceptible to disease. Ultimately, it is the goal 
of tendon defect repair to establish a repair site with a graft that is mechanically 
replicative of the original tendon properties and carries as little burden as possible.  
 
Artificial Grafts and Scaffolds 
Thus the use of artificial grafts or implants that can be crafted to desirable properties may 
be a viable alternative to take into consideration when developing novel graft 
replacements. Development of synthetic polymers includes grafts utilizing 
polyetrauoroethylene, PCL and PLGA. Investigations which explore the use of these 
grafts have been promising.  
 
One study using ePTFE grafts to treat chicken flexor tendon defects showed that 
engraftment led to the production of a tendon sheath which allows smooth integration 
into the surrounding tissues and also prevents adhesion formation. At three months, the 
junction areas of the defect between implant and natural tendon had a continuity that was 
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colonized by connective tissue. The connective tissue consisted of organized collagen 
fibers. At six months, the stumps were virtually the same as control tendon (Giorgetti et 
al., 2001). 
 
In another investigation, rabbits had their Achilles tendon transected and the defect 
repaired with a novel collagen implant. The collagen implant was prepared with extracted 
collagen type 1 from bovine superficial digital flexor tendon and the fibers were 
electrospun to be well-aligned. These collagen implants were not rejected and were 
shown to be biodegradable and had an important role in aligning the growth of new 
tissue. An inflammatory phase was observed for the first two weeks, but by 6 weeks post 
injury the injured area of animals observed no inflammatory reaction, had less 
peritendinous adhesion and fibrosis compared to controls (Meimandi-Parizi et al., 2013).  
 
Another group approached the use of synthetic grafts through a hybrid strategy and 
developed a scaffold that not only physically guided remodeling but supplied the defect 
site with growth factors, and cells in order to supplement/enhance the healing response.  
With a HBDS/PLGA scaffold, PDGF-BB and ASCs were delivered into the intrasynovial 
flexor tendons of mongrel dogs (Figure 13). While only 9 days post-surgery was 
evaluated in this study, results show that the delivered ASCs remained viable, and the cell 
population at the injury site increased. This increase in cell population could not be 
specified in the study, but either consisted of the ASCs or chemo attracted cells due to the 
agents delivered by the scaffold (Manning et al., 2013). 
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Figure 14. HBDS/PLGA Nanofiber scaffold. (A-D) Micrograph showing the HBDS/nanofiber 
scaffold in vitro; the PLGA was labelled with FITC (green), the HBDS was labeled with Alexa Fluor 546 (red), 
and the ASC nuclei were labeled with Hoescht 33258 (blue) (scale bar = 200 μm). (B inset) SEM image of the 
scaffold showing PLGA nanofiber alignment. (E) Micrograph showing the HBDS/nanofiber scaffold in vivo 9 
days after implantation in a tendon repair. Eleven alternating layers of PLGA and HBDS can be seen (i.e., 6 
layers of PLGA and 5 layers of fibrin); the PLGA was labelled with FITC (green) (scale bar = 100 μm). (F) A 
schematic of the layered scaffold is shown. (Taken from Manning et al., 2013) 
 
It is possible that the administration of growth factors while helpful for healing could 
have an adverse effect and promote adhesion formation, a complication that should 
ideally be avoided in order to achieve effective tendon remodeling. Given the success of 
a PLGA backbone in the delivery of growth factors and cells, and given the observations 
from other investigations which show the capacity to deliver factors which can counter 
adhesion, it is therefore feasible perhaps to devise an effective combination which could 
both improve healing and prevent adhesion.  
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Biological Factors for Tendon Therapy 
Thus, it appears worthwhile to investigate how other various biological factors may 
supplement tendon therapies. Single growth factors such as VEGF, cartilage derived 
morphogenetic protein, or PRP have been commonly investigated to see how they affect 
healing at the tendon defect site. One study demonstrated that a single dose of CDMP-2 
to healing rabbit tendons increased the tendon failure load by 35% without causing 
cartilage or ossification (Forslund et al. 2003).  
 
Replication of these results, in large mammals, and the deterrence of cartilage and bone 
formation within the tendinous tissue could suggest the viable utilization of CDMP-2 for 
future treatment of human tendon defects. A similar mechanical advantage, compared to 
control, was also achieved in an ovine model in which administration of CDMP-2 at the 
tendon defect site was delayed (Virchenko et al. 2008). 
 
VEGF 
VEGF is a factor well known for its angiogenic capabilities but also a factor that has 
potential use in accelerating tendon healing by containing the inflammatory response. 
VEGF injected into non sutured Achilles tendon defects, stimulated tendon healing and 
increase the mechanical tensile strength of the tendon. At 5 and 15 and 30 days the 
tendons in the VEGF treated group underwent tensile tests and compared to controls, 
tensile strength showed no advantages. However, at 30 days tensile strength tests reveal 
an improved tensile strength in the VEGF group. The molecular response responsible for 
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this improved mechanical strength was examined through mRNA analysis, though results 
show that no real difference existed in the expression of collagen 3, tnmd and or MMP-9 
(Kaux et al., 2014).  Furthermore, VEGF delivered into a chicken model exhibited 
expression changes demonstrated by greater collagen 3 expressions, MMP2 expression 
and significantly increase ultimate tensile strength of the tendons compared to control. 
This suggests VEGF as a potential option for future therapy, and if applied clinically, 
could be useful in reducing the rate of tendon re rupture following tendon surgical repair.  
 
Platelet Derived Therapies 
In the clinic already, platelet derivatives such as PRP, PC, and PRGF demonstrate 
potential effective use in treating tendon lesions. Indeed numerous studies have 
consistently shown the effectiveness of these platelet derivatives. One study use PRP in 
rupture tendon and observed an increase expression of IGF-1 in the early phase of 
healing. The growth factor localized in the epitenon and endotenon. The tendons were 
overall observed to heal more rapidly when treated with PRP compared to controls (Lyras 
et al., 2011). Other studies show the same results with injected PRP and PRGF in other 
models. Tendons in the PRP group were more resistant to rupture at 15 and 30 days and 
type 1 collagen was significantly increased at day 30 in the PRP group (Kaux et al., 
2012). In rats treated with PRP, the density of collagen type 1, was much greater than rats 
not receiving PRP and in rats receiving platelet poor plasma. Tensile strength tests 
demonstrate that the PRP groups exhibited higher tensile strengths than both the control 
and PPP group at 4 weeks (Xiong et al., 2012). 
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These results together encourage the continuous use of platelet rich plasma to enhance 
the healing in the situation of tendon repair. Discovery of other factors that may 
demonstrate equally beneficial effects may additionally improve outcomes in 
combination with or separate from platelet plasma therapies.  
 
GDF-5 
In one study of rat tendons, a dip-coating technique which coated sutures in a 
gelatin/recombinant human GDF-5 was employed on rat sutures to evaluate the effects of 
GDF-5 on tendon healing. Rat tendons with sutures exposed to GDF-5, demonstrate 
greater tendon stiffness and ability to withstand higher tensile load compared with use of 
control sutures. At 3 weeks GDF-5 treated group had greater rates of healing. While 
stiffness and load was greater than control sutured groups, mechanical properties were 
still unable to match contralateral unoperated tendons. There was no dose response effect 
reported however when different concentrations of GDF-5 were applied to sutures. It is 
possible that the lowest concentration of GDF-5 used was already a maximal effective 
dose and smaller doses and gradients would need to be administered in order to produce 
more observable effects (Dines et al., 2007). In this rat model, researchers do observe 
some mild deposition of cartilage and bone formation within the repair site that is 
actually not found histologically in a similar rabbit model (Henn et al., 2010).  
 
These results demonstrate that GDF-5 administration at least compared to no-
administration may have certain advantages in terms of tendon healing. Histological 
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observations of the rat model and the rabbit model grant us a reminder though to how 
important it is to employ an effective preclinical model when it comes to studying tendon 
pathology. While the rabbit showed no bone cartilage formation, rat models (which may 
or may not be more representative of human disease) do exhibit cartilage and bone 
formation within tendinous tissue. This bone cartilage may interfere with the 
functionality and the health of the tendon. 
 
GDF-5’s potential use as a positive tenogenic modulator is strengthened by the 
observation that exposure of hMSCs to different concentrations of GDF-5 led to 
upregulation of various candidate tenogenic marker genes (Scx, tn-C, type 1 collagen). 
GDF-5 treatment on hMSCs also led to the increased ratio of type 1 collagen to type 3. 
Finally, expression analysis identified the down regulation of various non tenogenic 
marker genes which excludes the hMSC from committing to other lineages (Tan et al., 
2012). Together these studies, suggest that GDF-5 has some kind of stimulatory activity 
which may favor tendon growth and/or the activation of tendon genes. It’s possible that a 
more focused activation of the signaling pathway evoked by the administration of GDF-5 
and that involved in the upregulation of the various endogenic genes may be of beneficial 
focus in future therapies. 
 
When it comes to tendon injury and severe tendon ruptures, surgical engraftment or 
scaffold guided healing will likely still hold the most practical chance for mechanical 
restoration at the site of tendon defect.  The results of current investigations taken 
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together, suggest that to develop an effective therapy will require the identification and 
effective delivery of factors which can stimulate effective matrix organization and 
reconstitution of tissue with the mechanical strength and function representative of the 
original tendon. Mechanistically the goals of growth factor therapy in tendon healing 
should not only focus on improving collagen deposition but also to improve 
vascularization and the stimulation of tenocytes to improve matrix production and 
organization. Furthermore, research which investigates the cause of clinical 
complications (like adhesion formation) can help guide development of improved 
treatments which circumvent or minimize the occurrence of complications often 
encountered in research and in the clinic. 
 
CONCLUSION 
While much research on the musculoskeletal system has focused on numerous aspects of 
non-tendinous tissue, recent emergence of tendon investigations have greatly expanded 
our understanding of tendon biology. In order to address and develop therapeutics to 
effectively treat tendon pathology, predictive animal models must be utilized. Animal 
models are important as they ease the translation of scientific research into clinical 
practice. Despite differential loading of tendons by various animals, these tendon models 
still provide investigators the best tool to evaluating biological responses to various 
treatments and manipulations. Animal models thus facilitate the investigation into 
understanding the mechanical, molecular and cellular mechanism needed to achieve 
effective healing. One aspect of tendon biology, that may prove an important strategy to 
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discovering viable clinical treatments, is elucidating the molecular mechanisms involved 
in the development of tendons. By understanding the developmental process of tendons, 
it may be possible to replicate certain aspects of this developmental program in the 
laboratory to stimulate improved healing.  
 
Tendons have a primary function in the transmission of muscular forces to produce 
skeletal movement and collagen fibrils in tendon underpin this function. Understanding 
the mechanical characteristics and how that ties into a cellular response in tendon will 
guide the development of synthetic grafts with mechanical properties that sufficiently 
emulate the tendon as well as agent-infused synthetic scaffolds that will help improve the 
healing response. 
 
Future research should continue to ask the many questions that current investigations 
have begun to describe. How do the various mechanical forces, shape the remodeling of 
tendon? In tendons, what physical mechanisms underlie mechanotransduction and allow 
the homeostatic organization of the matrix? In addition to tenocytes, what roles do other 
cell populations (such as TSPCs) have in the role of tendon growth, remodeling and in 
the healing response. Finally, clinically which strategies demonstrate promise to be 
employed in human therapies and further to minimize the complications of current 
therapies? The answers to these questions have begun to be revealed and will be of great 
importance in enhancing our understanding of tendon biology and the development of 
therapeutics for musculoskeletal disorders/injuries. 
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